CLINICAL_TRIALS
trial_result
· 2021-06-02
Clinical Trial Update: Extension Study to Assess the Safety and Efficacy of Pasireotide in Participants With Cushing's Disease [Phase 2]
Summary
Extension study evaluating safety and efficacy of pasireotide in participants with Cushing's disease (Phase 2; completed).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Cushing Disease | Phase 2 | Status: COMPLETED | Results posted: 2021-06-02